-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Is Johnson & Johnson Giving Up on Kenvue (KVUE) Stock?
An earlier-than-expected tender offer from Johnson & Johnson has shares of KVUE stock declining in today's session.
CTLT Stock Alert: What to Know as Elliott Takes a Stake in Catalent
Catalent (CTLT) stock is on the move Thursday as investors react to activist investor Elliott Investment taking a stake in the company.
Why Is Eliem Therapeutics (ELYM) Stock Up 6% Today?
Eliem Therapeutics (ELYM) stock is taking off on Thursday after the biotechnology company announced plans to explore strategic alternatives.
Why Is PainReform (PRFX) Stock Up 38% Today?
PainReform (PRFX) stock is rallying on Thursday after the pharmaceutical company regained compliance with Nasdaq listing requirements.
Did Nvidia Just Trigger a Short Squeeze in RXRX Stock?
Recursion Pharmaceuticals continues to rally higher, with RXRX stock now up more than 100% after Nvidia invested in the firm last week.
DNA Stock Alert: The $18 Milion Reason Ginkgo Bioworks Is Up Today
Ginkgo Bioworks (DNA) stock is rising higher on Wednesday after the company won a four-year, $18 million contract from DARPA.
TDOC Stock Alert: Teladoc Doubles Down on Microsoft AI Partnership
Teladoc (TDOC) stock is on the move Tuesday as the company expands its Microsoft (MSFT) AI partnership to enhance Teladoc Health Solo.
Why Is CEL-SCI (CVM) Stock Down 23% Today?
CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering.
Why Is Masimo (MASI) Stock Down 30% Today?
Masimo (MASI) stock is taking a beating on Tuesday after the patient monitoring tech company released preliminary earnings for Q2 2023.
Why Is Karyopharm Therapeutics (KPTI) Stock Up 21% Today?
Karyopharm Therapeutics (KPTI) stock is climbing higher on Tuesday after getting fast-track designation for its myelofibrosis treatment.
Why Is Biophytis (BPTS) Stock Up 66% Today?
Biophytis (BPTS) stock is rocketing higher on Tuesday following after announcing a production partnership with SEQENS for Sarconeos.